PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 38 filers reported holding PROTARA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,380 | -30.1% | 20,587 | 0.0% | 0.00% | – |
| Q2 2023 | $49,203 | -23.6% | 20,587 | 0.0% | 0.00% | – |
| Q1 2023 | $64,437 | +20.1% | 20,587 | +2.8% | 0.00% | – |
| Q4 2022 | $53,651 | -9.1% | 20,019 | 0.0% | 0.00% | – |
| Q3 2022 | $59,000 | 0.0% | 20,019 | 0.0% | 0.00% | – |
| Q2 2022 | $59,000 | -42.2% | 20,019 | 0.0% | 0.00% | – |
| Q1 2022 | $102,000 | -32.0% | 20,019 | -9.9% | 0.00% | – |
| Q4 2021 | $150,000 | -2.6% | 22,215 | -0.3% | 0.00% | – |
| Q3 2021 | $154,000 | -29.0% | 22,279 | 0.0% | 0.00% | – |
| Q2 2021 | $217,000 | -75.7% | 22,279 | -60.7% | 0.00% | – |
| Q1 2021 | $892,000 | -41.7% | 56,676 | -10.3% | 0.00% | – |
| Q4 2020 | $1,530,000 | +146.4% | 63,212 | +71.3% | 0.00% | – |
| Q3 2020 | $621,000 | +28.0% | 36,894 | +123.3% | 0.00% | – |
| Q2 2020 | $485,000 | – | 16,523 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,692,594 | $4,496,632 | 1.46% |
| Privium Fund Management (UK) Ltd | 119,730 | $201,146 | 0.16% |
| Ikarian Capital, LLC | 188,664 | $315,069 | 0.04% |
| Orbimed Advisors | 772,584 | $1,290,215 | 0.03% |
| Boxer Capital, LLC | 209,227 | $349,409 | 0.02% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 64,000 | $106,880 | 0.00% |
| Baker Brothers Advisors | 199,671 | $333,451 | 0.00% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,864 | $31,503 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 27,345 | $45,666 | 0.00% |
| OSAIC HOLDINGS, INC. | 100 | $167 | 0.00% |